TRAF4 Polyclonal Antibody

TRAF4 (TNF receptor associated factor 4) encodes a member of the TNF receptor associated factor (TRAF) family. TRAF proteins are associated with, and mediate signal transduction from members of the TNF receptor superfamily. The encoded protein has been shown to interact with neurotrophin receptor, p75 (NTR/NTSR1), and negatively regulate NTR induced cell death and NF-kappa B activation. This protein has been found to bind to p47phox, a cytosolic regulatory factor included in a multi-protein complex known as NAD(P)H oxidase. This protein thus, is thought to be involved in the oxidative activation of MAPK8/JNK. Alternatively spliced transcript variants have been observed but the full-length nature of only one has been determined.

The TRAF4 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of TRAF4 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, ensuring its exceptional sensitivity and specificity.

TRAF4, also known as TNF receptor-associated factor 4, is a crucial component of the tumor necrosis factor (TNF) signaling pathway. It plays a pivotal role in regulating diverse cellular processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of TRAF4 has been implicated in various diseases, such as cancer and autoimmune disorders.

The TRAF4 Polyclonal Antibody exhibits outstanding performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of TRAF4 protein, enabling accurate quantification and localization studies. This antibody demonstrates minimal cross-reactivity with other related proteins, ensuring reliable and specific results.

With its high affinity and sensitivity, the TRAF4 Polyclonal Antibody is an indispensable tool for researchers and scientists involved in studying the TNF signaling pathway and its associated diseases. Its exceptional quality and performance make it an ideal choice for both basic research and clinical applications.

Each batch of the TRAF4 Polyclonal Antibody undergoes rigorous quality control procedures to ensure consistent and reliable results. It is supplied as a liquid formulation, ready for immediate use, and is available in various sizes to meet the diverse needs of researchers.

In summary, the TRAF4 Polyclonal Antibody is a highly specific and reliable tool that enables accurate detection and analysis of TRAF4 protein expression. Its exceptional quality, sensitivity, and specificity make it an invaluable asset for researchers and scientists in the field of TNF signaling pathway research.